408 related items for PubMed ID: 11793859
41. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V.
J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
[Abstract] [Full Text] [Related]
42. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
[Abstract] [Full Text] [Related]
43. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
Chishti AS, Sorof JM, Brewer ED, Kale AS.
Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
[Abstract] [Full Text] [Related]
44. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM, Catarsi P, Scolari F, Caridi G, Bertelli R, Carrea A, Sanna-Cherchi S, Emma F, Allegri L, Cancarini G, Rizzoni GF, Perfumo F.
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[Abstract] [Full Text] [Related]
45. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
[Abstract] [Full Text] [Related]
46. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.
Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ.
Nephrol Dial Transplant; 2004 May; 19(5):1136-41. PubMed ID: 14993510
[Abstract] [Full Text] [Related]
47. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
Meyrier A.
J Nephrol; 1997 May; 10(1):14-24. PubMed ID: 9241620
[Abstract] [Full Text] [Related]
48. Effectiveness of steroid therapy in different stages of membranous nephropathy.
Fuiano G, Stanziale P, Balletta M, Sepe V, Marinelli G, Comi N, Esposito A, Andreucci VE.
Nephrol Dial Transplant; 1989 May; 4(12):1022-9. PubMed ID: 2517322
[Abstract] [Full Text] [Related]
49. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
Heering P, Schneider A, Grabensee B, Plum J.
Dtsch Med Wochenschr; 2001 Oct 05; 126(40):1093-8. PubMed ID: 11588659
[Abstract] [Full Text] [Related]
50. Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.
Matsumoto H, Nagaoka Y, Okada T, Wada T, Gondo A, Esaki S, Hayashi A, Miyaoka Y, Nakao T.
Intern Med; 2011 Oct 05; 50(18):1905-10. PubMed ID: 21921367
[Abstract] [Full Text] [Related]
51. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
Passerini P, Pasquali S, Cesana B, Zucchelli P, Ponticelli C.
Nephrol Dial Transplant; 1989 Oct 05; 4(6):525-9. PubMed ID: 2507973
[Abstract] [Full Text] [Related]
52. [Clinical outcome assessment of membranous nephropathy].
Kumagai T, Shimizu H, Nishi T, Mise N, Tagawa H, Sugimoto T.
Nihon Jinzo Gakkai Shi; 2005 Oct 05; 47(8):870-5. PubMed ID: 16408431
[Abstract] [Full Text] [Related]
53. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE, Pamuk ON, Başlar Z, Ongören S, Soysal T, Ferhanoğlu B, Aydin Y, Ulkü B, Aktuğlu G, Akman N.
Ann Hematol; 2002 Aug 05; 81(8):436-40. PubMed ID: 12224000
[Abstract] [Full Text] [Related]
54. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC, Sethi S, Specks U.
Clin J Am Soc Nephrol; 2008 May 05; 3(3):905-19. PubMed ID: 18235148
[Abstract] [Full Text] [Related]
55. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF, Brodeh J.
J Am Soc Nephrol; 2006 Apr 05; 17(4):1151-7. PubMed ID: 16540560
[Abstract] [Full Text] [Related]
56. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
du Buf-Vereijken PW, Wetzels JF.
Nephrol Dial Transplant; 2006 Feb 05; 21(2):389-96. PubMed ID: 16234291
[Abstract] [Full Text] [Related]
57. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
[Abstract] [Full Text] [Related]
58. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, McLean AG, Palmer A, Taube D.
Nephrol Dial Transplant; 2004 Dec 15; 19(12):3062-7. PubMed ID: 15507477
[Abstract] [Full Text] [Related]
59. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S.
N Engl J Med; 1989 Jan 26; 320(4):210-5. PubMed ID: 2643046
[Abstract] [Full Text] [Related]
60. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG.
Clin Nephrol; 1995 Sep 26; 44(3):156-62. PubMed ID: 8556831
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
